11/20/2026 | Press release | Distributed by Public on 11/20/2026 18:36
|
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | |||
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Nqso (Right to Buy) | 05/05/2022(4) | 05/05/2030 | Common Stock | 5,314 | $236.36 | D | |
| Nqso (Right to Buy) | 04/30/2023(5) | 04/30/2031 | Common Stock | 5,434 | $239.64 | D | |
| Nqso (Right to Buy) | 08/06/2023(6) | 08/06/2031 | Common Stock | 40,595 | $230.15 | D | |
| Nqso (Right to Buy) | 05/02/2024(7) | 05/02/2032 | Common Stock | 7,070 | $230.92 | D | |
| Nqso (Right to Buy) | 05/02/2025(8) | 05/02/2033 | Common Stock | 7,166 | $235.97 | D | |
| Nqso (Right to Buy) | 05/07/2026(9) | 05/07/2034 | Common Stock | 4,326 | $300.3 | D | |
| Nqso (Right to Buy) | 05/06/2026(10) | 05/06/2035 | Common Stock | 6,214 | $270.44 | D | |
| Nqso (Right to Buy) | 05/05/2027(11) | 05/05/2036 | Common Stock | 5,146 | $329.59 | D | |
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Paulino Arleen ONE AMGEN CENTER DRIVE THOUSAND OAKS, CA 91320 |
EVP, Operations | |||
| Andrea A. Robinson, attorney-in-fact for Ms. Paulino | 11/20/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | These shares include 2,181 Restricted Stock Units (RSUs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan). Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |
| (2) | These shares include 66 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
| (3) | These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |
| (4) | 5,314 of these non-qualified stock options have vested and are exercisable. |
| (5) | 5,434 of these non-qualified stock options have vested and are exercisable. |
| (6) | 40,595 of these non-qualified stock options have vested and are exercisable. |
| (7) | 7,070 of these non-qualified stock options have vested and are exercisable. |
| (8) | 4,729 of these non-qualified stock options have vested and the remaining options will vest and become exercisable on 5/2/2027. |
| (9) | 1,427 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in two annual installments, commencing on 5/7/2027. |
| (10) | 1,553 of these non-qualified stock options have vested and the remaining options will vest and become exercisable in three annual installments, commencing on 5/6/2027. |
| (11) | These non-qualified stock options will vest and become exercisable in four equal annual installments of 25% each, commencing on 5/5/2027. |